Rxivist logo

Author: Alejandra Gurtman

  • Most recently observed institution: Vaccine Research and Development, Pfizer, Inc.

Rankings

  • All-time downloads: 132,896 (rank: 658 (tie) )
  • Categories:
    • infectious diseases: 132,896 (rank: 173 (tie) )

Downloads per author, site-wide

Preprints

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 68,181 times
  • Download rankings, all-time:
    • Site-wide: 77
    • In infectious diseases: 30
  • Year to date:
    • Site-wide: 204
  • Since beginning of last month:
    • Site-wide: 234

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 64,715 times
  • Download rankings, all-time:
    • Site-wide: 82
    • In infectious diseases: 32
  • Year to date:
    • Site-wide: 80
  • Since beginning of last month:
    • Site-wide: 168

PanLingua

News